Completed PHASE1 INTERVENTIONAL 2-arm NCT05316259

A Food-Effect Study of BPI-16350 in Healthy Subjects

A Phase 1, Single-center, Open-Label, Randomized, 2 Period Crossover Study to Estimate the Effect of Food on the Pharmacokinetics of BPI-16350 in Chinese Healthy Volunteers After a Single Oral Administration

Sponsor: Betta Pharmaceuticals Co., Ltd.

Conditions Healthy

Interventions BPI-16350

Updated 5 times since 2022 Last updated: May 7, 2023 Started: Apr 15, 2022 Primary completion: Aug 30, 2022 Completion: Aug 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Healthy, this trial is completed. The trial is conducted by Betta Pharmaceuticals Co., Ltd. and has accumulated 5 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jun 2023 — Jul 2024 [monthly]

Completed PHASE1

Status: Active Not Recruiting → Completed
Jul 2022 — Jun 2023 [monthly]

Active Not Recruiting PHASE1

Status: Recruiting → Active Not Recruiting
May 2022 — Jul 2022 [monthly]

Recruiting PHASE1

First recorded

Apr 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Betta Pharmaceuticals Co., Ltd.

Data source: Betta Pharmaceuticals Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China